163 related articles for article (PubMed ID: 3293526)
1. Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid.
Bodhidatta L; Taylor DN; Chitwarakorn A; Kuvanont K; Echeverria P
Antimicrob Agents Chemother; 1988 May; 32(5):723-5. PubMed ID: 3293526
[TBL] [Abstract][Full Text] [Related]
2. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole.
Bogaerts J; Kestens L; Martinez Tello W; Akingeneye J; Mukantabana V; Verhaegen J; Van Dyck E; Piot P
Clin Infect Dis; 1995 Apr; 20(4):924-30. PubMed ID: 7795096
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial.
Naamara W; Plummer FA; Greenblatt RM; D'Costa LJ; Ndinya-Achola JO; Ronald AR
Am J Med; 1987 Apr; 82(4A):317-20. PubMed ID: 3555055
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a single dose therapy of a 500 mg ciprofloxacin tablet in chancroid patients.
Traisupa A; Wongba C; Tesavibul P
Infection; 1988; 16 Suppl 1():S44-5. PubMed ID: 3286513
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial therapy of chancroid: effectiveness of erythromycin.
Plummer FA; D'Costa LJ; Nsanze H; Maclean IW; Karasira P; Piot P; Fast MV; Ronald AR
J Infect Dis; 1983 Oct; 148(4):726-31. PubMed ID: 6355314
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya.
Malonza IM; Tyndall MW; Ndinya-Achola JO; Maclean I; Omar S; MacDonald KS; Perriens J; Orle K; Plummer FA; Ronald AR; Moses S
J Infect Dis; 1999 Dec; 180(6):1886-93. PubMed ID: 10558945
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya.
MacDonald KS; Cameron DW; D'Costa L; Ndinya-Achola JO; Plummer FA; Ronald AR
Antimicrob Agents Chemother; 1989 May; 33(5):612-4. PubMed ID: 2502065
[TBL] [Abstract][Full Text] [Related]
9. Cefotaxime treatment of Haemophilus ducreyi infection in Kenya.
Plummer FA; Maggwa N; D'Costa LJ; Nsanze H; Karasira P; Maclean IW; Ronald AR
Sex Transm Dis; 1984; 11(4):304-7. PubMed ID: 6098034
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
Fast MV; Nsanze H; D'Costa LJ; Plummer FA; Karasira P; Maclean IW; Ronald AR
Lancet; 1982 Sep; 2(8297):509-11. PubMed ID: 6125676
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
Ismaeel NA
Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance of Haemophilus ducreyi.
Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
[TBL] [Abstract][Full Text] [Related]
14. Single-dose therapy of chancroid with trimethoprim-sulfametrole.
Plummer FA; Nsanze H; D'Costa LJ; Karasira P; Maclean IW; Ellison RH; Ronald AR
N Engl J Med; 1983 Jul; 309(2):67-71. PubMed ID: 6343878
[TBL] [Abstract][Full Text] [Related]
15. Treatment of chancroid with a single dose of spectinomycin.
Guzmán M; Guzmán J; Bernal M
Sex Transm Dis; 1992; 19(5):291-4. PubMed ID: 1411847
[TBL] [Abstract][Full Text] [Related]
16. Prevention of experimental Haemophilus ducreyi infection: a randomized, controlled clinical trial.
Thornton AC; O'Mara EM; Sorensen SJ; Hiltke TJ; Fortney K; Katz B; Shoup RE; Hood AF; Spinola SM
J Infect Dis; 1998 Jun; 177(6):1608-13. PubMed ID: 9607840
[TBL] [Abstract][Full Text] [Related]
17. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.
Van Dyck E; Bogaerts J; Smet H; Tello WM; Mukantabana V; Piot P
Antimicrob Agents Chemother; 1994 Jul; 38(7):1647-8. PubMed ID: 7979300
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim sulphamoxole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen.
Dylewski J; Nsanze H; D'Costa L; Slaney L; Ronald A
J Antimicrob Chemother; 1985 Jul; 16(1):103-9. PubMed ID: 3876325
[TBL] [Abstract][Full Text] [Related]
19. Single-dose ceftriaxone for chancroid.
Bowmer MI; Nsanze H; D'Costa LJ; Dylewski J; Fransen L; Piot P; Ronald AR
Antimicrob Agents Chemother; 1987 Jan; 31(1):67-9. PubMed ID: 3566241
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chancroid, 1989.
Schmid GP
Rev Infect Dis; 1990; 12 Suppl 6():S580-9. PubMed ID: 2201074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
